Paragon 28 Completes Series B Financing

关注订阅预警-> 医药魔方数据库2020-08-18

Paragon 28, Inc., an Englewood, Colo.-based orthopedic foot and ankle company, completed a Series B financing of undisclosed amount. 

The round was co-led by Piper Sandler Merchant Banking, a commercial stage growth equity investment business of Piper Sandler Companies, and MVM Partners, a healthcare growth equity investment firm.  The financing also included participation from an existing Series A investor.

The new financing will support Paragon 28’s ongoing initiatives to develop and launch new products, including the recently FDA cleared APEX 3DTM Total Ankle Replacement System, as well as continued commercial expansion in the US and international markets.

led by Albert DaCosta, President and CEO, Paragon 28 creates new and improved solutions to the challenges faced by foot and ankle specialists.

The company provides the APEX 3D™ Total Ankle Replacement System, and a Precision Ankle Solutions product offering, which includes the Gorilla® Ankle Fracture Plating System, Silverback® Ankle Fusion Plating System, and Phantom™ TTC Fusion Nail Systems.

FinSMEs

17/08/2020 

资讯来源:FinSMEs 查看原文

点我获取更多
免费体验医药二级市场投资神器,快到碗里来
医药投资人想了解国内产业园区情况?这个工具完美帮您解决!
阅读 217